Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hadam

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Zeitschrift Fur Rheumatologie|November 1, 1984
Distribution of mast cells in human synovial tissue of patients with osteoarthritis and rheumatoid arthritisP Fritz, J Müller, H Reiser, et al.
Cancer Research|December 1, 1991
Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypesE L Hänninen, A Körfer, M Hadam, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2J Atzpodien, H Kirchner, A Körfer, et al.
Cancer Biotherapy|January 1, 1993
Clinical and preclinical evaluation of recombinant PEG-IL-2 in humanT Menzel, A Schomburg, A Körfer, et al.
Acta Haematologica|January 1, 1993
Low-dose interleukin-2 in combination with interferon-alpha effectively modulates biological response in vivoC Schneekloth, A Körfer, M Hadam, et al.
Cancer|April 1, 1991
The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2H Kirchner, A Körfer, P Evers, et al.
Molecular Biotherapy|March 1, 1990
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient studyJ Atzpodien, A Körfer, P Evers, et al.
Molecular Biotherapy|September 1, 1990
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experienceH Kirchner, A Körfer, P A Palmer, et al.
Journal of Leukocyte Biology|November 8, 2001
CD antigens 2001D Mason, P André, A Bensussan, et al.
Tissue Antigens|April 4, 2002
CD antigens 2001D Y Mason, P André, A Bensussan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Zeitschrift Fur Rheumatologie|November 1, 1984
Distribution of mast cells in human synovial tissue of patients with osteoarthritis and rheumatoid arthritisP Fritz, J Müller, H Reiser, et al.
Cancer Research|December 1, 1991
Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypesE L Hänninen, A Körfer, M Hadam, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2J Atzpodien, H Kirchner, A Körfer, et al.
Cancer Biotherapy|January 1, 1993
Clinical and preclinical evaluation of recombinant PEG-IL-2 in humanT Menzel, A Schomburg, A Körfer, et al.
Acta Haematologica|January 1, 1993
Low-dose interleukin-2 in combination with interferon-alpha effectively modulates biological response in vivoC Schneekloth, A Körfer, M Hadam, et al.
Cancer|April 1, 1991
The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2H Kirchner, A Körfer, P Evers, et al.
Molecular Biotherapy|March 1, 1990
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient studyJ Atzpodien, A Körfer, P Evers, et al.
Molecular Biotherapy|September 1, 1990
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experienceH Kirchner, A Körfer, P A Palmer, et al.
Journal of Leukocyte Biology|November 8, 2001
CD antigens 2001D Mason, P André, A Bensussan, et al.
Tissue Antigens|April 4, 2002
CD antigens 2001D Y Mason, P André, A Bensussan, et al.
Pageof 3